The Foundation for Cancer Research Support (RakFond)

About the Foundation

The Foundation for Cancer Research Support (RakFond) is a non-profit organization with the main objectives of:
  • funding R&D activities and the development of new methods and tools for the prevention, diagnosis and treatment of cancer;
  • promoting the advancement of research activities of scientific institutions, centers, oncological hospitals, and individual specialists in the field of oncology.

The Foundation was founded in 2017 and operates in the Russian Federation.

Support our Work! RakFond’s Strategy

 

News

Joint Session of RUSSCO and RakFond with Consilium Scientific PRESENT AND FUTURE OF ONCOLOGY Chairs: Dr. Nikolay Zhukov, D. Rogachev ...
Read more
отчет AACR РакФонд
DISCOVERY SCIENCE DRIVING CLINICAL BREAKTHROUGHS The American Association for Cancer Research (AACR) released its annual Cancer Progress Report, which highlights ...
Read more
David Julius and Ardem Patapoutian were awarded the Nobel Prize in Physiology or Medicine in 2021. Their discoveries were focused ...
Read more
This year's meeting of the European Society for Medical Oncology (ESMO) took place online on September 16-21. In frames of ...
Read more
ASCO’s Clinical Cancer Advances annual report highlights current trends in the field and identifies cancer research priorities that have great ...
Read more
View all News

 

Articles and Reviews

View All Articles and Reviews

 

Interviews with Experts

RakFond’s experts talk in their short interviews about their choice to become an oncologist, which cancer research they could name as their favorite, and why cancer research support is important.

Interview with Tatiana Semiglazova, MD, DSci, Professor, Head of Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N.N. Petrov National Medical Research Center of Oncology (St. Petersburg, Russia), Professor at the Department of Oncology, I.I. Mechnikov North-Western State Medical University (St. Petersburg, Russia), Board member of the Russian Society of Clinical Oncology (RUSSCO), Member of RakFond’s Scientific Advisory Board.

The topic of the interview is the rehabilitation of cancer patients. Learn more about physical, metabolic, and psychological rehabilitation, and how it affects the outcomes of cancer patients treatment.

Interview with Andrei Gudkov, Ph.D., D.Sci., Senior Vice President, Research Technology and Innovation, Chair, Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA), Member of RakFond’s Scientific Advisory Board.

Learn about the relationship between cancer and evolution, what the scientists may be proud of, and where the curiosity leads us. 

Interview with Katerina Gurova, M.D., Ph.D., Professor of Oncology, Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA), Member of RakFond’s Scientific Advisory Board.

Learn about the regulation of reading in the library of genes, the role of the “gene of conscience” in carcinogenesis and how we can learn to control cancer.

Interview with Jacek Gronwald, PhD, Professor, Department of Genetics and Pathology, Pomeranian Medical University (Szczecin, Poland), Member of RakFond’s Scientific Advisory Board.

Learn about hereditary cancers, studies of lifestyle factors in oncology, and why every research is some kind of a startup.

Interview with Alexey Danilov, Associate Professor of Medicine, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University (Portland, USA), Member of RakFond’s Scientific Advisory Board.

Learn about research translation from bench to bedside, the discovery and research of the novel therapies in hematologic malignancies, the support of research initiatives by private foundations and how to see the diagnosis with one’s own eyes.

Interview with Alexey Tryakin, M.D., D.Sci., Chief Scientist, Department of Clinical Pharmacology and Chemotherapy of N.N. Blokhin National Medical Research Center of Oncology (Moscow, Russia), ESMO National Representative in the Russian Federation, Board member of the Russian Society of Clinical Oncology (RUSSCO), Member of RakFond’s Scientific Advisory Board.

Learn about the inception of the targeted therapy in oncology, what advantages of participating in clinical trials bring to doctors and patients in Russia, and why there should be even more research.

View All Interviews with Experts